TP53 mutations were not significantly associated with shorter median OS compared to TP53 wild-type tumours (24.1 months [95%-CI: 19.2–38.4] versus 28.0 [95%-CI: 22.7–38.9] months; HR: 1.22 [95%-CI: 0.84–1.78]; p = 0.289). Here, TP53 is linked to neoplasm.